Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 5Expanded_access 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Cutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory 1

Interventions

nilotinib 5dabrafenib 4Nivolumab 4Afatinib 4trametinib 3regorafenib 3midostaurin 3elotuzumab 3TIC10 compound 3Sunitinib 3Prednisone 3Capecitabine 3Abiraterone Acetate 33-Iodobenzylguanidine 3venetoclax 2tucatinib 2tempol 2tazemetostat 2talquetamab 2talimogene laherparepvec 2ruxolitinib 2pomalidomide 2olaparib 2niraparib 2leronlimab 2lenvatinib 2ibrutinib 2gilteritinib 2ceritinib 2brexucabtagene autoleucel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Expanded_access × Rose Bengal × Clear all
NCT01260779 2016-07-11

Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors

Provectus Pharmaceuticals

No longer available
Dermatologic

Cutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡